i2o Therapeutics
Pre-clinicalDevelops oral biologic drug delivery technologies using intestinal targeting platforms.
Founded
2020
Focus
Drug Delivery
About
Develops oral biologic drug delivery technologies using intestinal targeting platforms.
Funding History
2Total raised: $43M
Series A$35MF-Prime CapitalAug 15, 2022
Seed$8MAtlas VentureMar 15, 2021
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile